Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Predictive Markers in GHD and TS Children Treated With SAIZEN®

This study has been completed.
Information provided by:
Merck KGaA Identifier:
First received: November 18, 2005
Last updated: March 26, 2014
Last verified: March 2014